Abiopharma

News list

TSAI HSIEN-SHU 🟡 adjusted position in 0 shares (1 derivative) of Apollomics Inc. (APLM) Transaction Date: Jun 15, 2026 | Filing ID: 272835

Full text

News bot June 16, 2026, 9:06 p.m.
🔍 TSAI HSIEN-SHU (Executive)

Company: Apollomics Inc. (APLM)

Report Date: 2026-06-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 500
- Total shares sold: 500
Detailed Transactions and Holdings:
- Acquired 500 shares of CLASS A ORDINARY SHARES (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: false | shares_owned_after: 1,500.00 | transaction_form_type: 4
- Sold 500 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: false | shares_owned_after: 500.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
- F2: RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 500 shares vested on each of February 9, 2026, March 15, 2026, and June 15, 2026, and an additional 500 shares will vest on September 15, 2026. This transaction represents the vesting of 500 RSUs on June 15, 2026.